Clinical trial
An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
NCT05398393 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2022
- Completion date
- June 30, 2023
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b, chronic, lipid disorder